| 4/17/2013 | CVIGLM | Boston Private shifts to more fee-based revenue; Q1 net income up 39%
|
| 2/1/2013 | CVLM | Boston Private buys back $9.1 million of convertible trust preferreds
|
| 10/22/2012 | CVLM | Boston Private buys back $9 million of convertible trust preferreds
|
| 7/20/2012 | CVLM | Boston Private buys back $5.75 million of convertible trust preferreds
|
| 11/30/2009 | CV | Boston Private buys back $44.5 million convertible trust preferreds
|
| 4/21/2009 | CVIG | Boston Private Financial files $225 million shelf with convertibles
|
| 4/30/2008 | CV | Boston Private Financial buys back $86.5 million 3% contingent convertibles
|
| 4/25/2008 | CV | Market Commentary: AirTran stays quiet; Ford holds firm; Boston Private gets support; Charming Shoppes, Cheniere see interest
|
| 3/26/2008 | CV | Boston Private Financial buys back $107.5 million 3% contingent convertibles
|
| 2/21/2008 | CV | Market Commentary: Nasdaq shoot higher despite aggressive pricing; Silver Standard muted in gray; Boston Private holds firm
|
| 6/29/2007 | CV | Market Commentary: Boston Private, Parker Drilling move up early; Fair Isaac jumps
|
| 6/29/2007 | CV | New Issue: Boston Private prices $250 million contingent convertibles to yield 3%, up 22.5%
|
| 6/28/2007 | CV | Market Commentary: Boston Private, Parker seen fair; Huntsman rated buy; Red Hat taken down; Ford motors on
|
| 6/27/2007 | CV | Boston Private launches $250 million contingent convertibles to yield 2.75% to 3.25%, up 20% to 25%
|
| 6/27/2007 | CV | Market Commentary: Gannett fails to excite; GSI Commerce goes big; IXYS backs out; Boston Private jumps in
|
| 3/15/2005 | CV | Boston Private Financial files $225 million shelf
|
| 10/27/2004 | CV | Boston Private greenshoe exercised, raising convertibles to $105 million
|
| 10/6/2004 | CV | New Issue: Boston Private advances deal, sells $75 million convertible preferreds at 4.875%, up 36.5%
|
| 10/6/2004 | CV | Market Commentary: Boston Private advances deal; Chiron spreads widen, AMD tighter; Sirius firms on Stern deal
|
| 10/5/2004 | CV | Market Commentary: General Mills issue rises; Chiron, Henry Schein fall on flu scare but MedImmune gains
|
| 10/4/2004 | CV | Boston Private $75 million convertible preferreds talked at 4.5% to 5.0%, up 35% to 40%
|
| 10/4/2004 | CV | Market Commentary: Lehman deal exchangeable into General Mills bid up in gray market; Boston Private deal emerges
|
